LevinsonNM, BoxerSG. 2012. Structural and spectroscopic analysis of the kinase inhibitor bosutinib and an isomer of bosutinib binding to the Abl tyrosine kinase domain. PLoS One, 7:e29828
3.
HalfordB. 2012. Bosutinib buyer beware. Molecule mix-up: the wrong isomer has been sold under the name of the cancer-fighting compound. In: Chemical and Engineering News. May11.